Sanofi (SNY) Short Interest Ratio & Short Volume → Next President (Not Trump. Not Biden.) (From The Freeport Society) (Ad) Free SNY Stock Alerts $49.98 +0.70 (+1.42%) (As of 12:15 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Sanofi Short Interest DataCurrent Short Volume5,440,000 sharesPrevious Short Volume3,240,000 sharesChange Vs. Previous Month+67.90%Dollar Volume Sold Short$267.81 millionShort Interest Ratio / Days to Cover2.7Last Record DateApril 30, 2024Outstanding Shares2,529,610,000 sharesShort Percent of Float0.22%Today's Trading Volume632,866 sharesAverage Trading Volume1,978,416 sharesToday's Volume Vs. Average32% Short Selling Sanofi ? Sign up to receive the latest short interest report for Sanofi and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSNY Short Interest Over TimeSNY Days to Cover Over TimeSNY Percentage of Float Shorted Over Time Ad Allegiance GoldDoes this make you sick?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit Sanofi Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20245,440,000 shares $267.81 million +67.9%0.2%2.7 $49.23 4/15/20243,240,000 shares $149.82 million -16.9%0.1%1.6 $46.24 3/31/20243,900,000 shares $189.54 million -15.0%0.2%2.1 $48.60 3/15/20244,590,000 shares $221.65 million +6.5%0.2%2.6 $48.29 2/29/20244,310,000 shares $206.23 million +6.2%0.2%2.4 $47.85 2/15/20244,060,000 shares $188.34 million -10.6%0.2%2.4 $46.39 Get the Latest News and Ratings for SNY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sanofi and its competitors with MarketBeat's FREE daily newsletter. 1/31/20244,540,000 shares $226.55 million -19.7%0.2%2.6 $49.90 1/15/20245,650,000 shares $294.99 million +22.3%0.2%2.8 $52.21 12/31/20234,620,000 shares $229.75 million +3.4%0.2%2.3 $49.73 12/15/20234,470,000 shares $213.13 million +13.7%0.2%2.1 $47.68 11/30/20233,930,000 shares $183.73 million +5.4%0.2%1.9 $46.75 11/15/20233,730,000 shares $169.42 million -25.4%0.2%1.9 $45.42 10/31/20235,000,000 shares $226.25 million +10.1%0.2%2.6 $45.25 10/15/20234,540,000 shares $247.57 million -0.4%0.2%3.1 $54.53 9/30/20234,560,000 shares $244.60 million +24.6%0.2%3.3 $53.64 9/15/20233,660,000 shares $199.62 million +7.0%0.2%3 $54.54 8/31/20233,420,000 shares $181.88 million +1.2%0.1%2.8 $53.18 8/15/20233,380,000 shares $178.46 million -18.9%0.1%2.7 $52.80 7/31/20234,170,000 shares $222.55 million -8.6%0.2%3.2 $53.37 7/15/20234,560,000 shares $240.22 million -6.6%0.2%3.5 $52.68 6/30/20234,880,000 shares $263.03 million +15.1%0.2%3.5 $53.90 6/15/20234,240,000 shares $219.59 million +11.3%0.2%2.7 $51.79 5/31/20233,810,000 shares $194.39 million +3.3%0.2%2.3 $51.02 5/15/20233,690,000 shares $201.25 million +2.8%0.2%2.1 $54.54 4/30/20233,590,000 shares $192.60 million No Change0.1%2 $53.65 4/15/20233,590,000 shares $201.58 million +23.4%0.1%1.9 $56.15 3/31/20232,910,000 shares $158.36 million +5.1%0.1%1.4 $54.42 3/15/20232,770,000 shares $131.77 million +1.1%0.1%1.4 $47.57 2/28/20232,740,000 shares $128.37 million +16.1%0.1%1.2 $46.85 2/15/20232,360,000 shares $111.51 million -12.9%0.1%1 $47.25 1/31/20232,710,000 shares $133.17 million -8.5%0.1%1.1 $49.14 1/15/20232,960,000 shares $145.84 million +6.9%0.1%1.1 $49.27 12/30/20222,770,000 shares $134.15 million -2.5%0.1%1 $48.43 12/15/20222,840,000 shares $133.93 million +11.4%0.1%0.9 $47.16 11/30/20222,550,000 shares $115.64 million -45.0%0.1%0.8 $45.35 11/15/20224,640,000 shares $202.07 million -12.6%0.2%1.6 $43.55 10/31/20225,310,000 shares $229.55 million +7.3%0.2%1.5 $43.23 10/15/20224,950,000 shares $195.92 million +34.2%0.2%1.5 $39.58 9/30/20223,690,000 shares $140.29 million -5.6%0.2%1.2 $38.02 9/15/20223,910,000 shares $159.02 million -18.4%0.2%1.3 $40.67Does this chart look familiar? (Ad)Investors who understand when to get in — and when to get out… Can make a lot of money. Like in the chart, I showed you above…Get all the information here. SNY Short Interest - Frequently Asked Questions What is Sanofi's current short interest? Short interest is the volume of Sanofi shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 5,440,000 shares of SNY short. 0.22% of Sanofi's shares are currently sold short. Learn More on Sanofi's current short interest. What is a good short interest ratio for Sanofi? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNY shares currently have a short interest ratio of 3.0. Learn More on Sanofi's short interest ratio. Which institutional investors are shorting Sanofi? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Sanofi: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Sanofi? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.22% of Sanofi's floating shares are currently sold short. Is Sanofi's short interest increasing or decreasing? Sanofi saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 5,440,000 shares, an increase of 67.9% from the previous total of 3,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sanofi's short interest compare to its competitors? 0.22% of Sanofi's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Sanofi: Regeneron Pharmaceuticals, Inc. (1.43%), Vertex Pharmaceuticals Incorporated (1.50%), Pfizer Inc. (1.10%), GSK plc (0.44%), Bristol-Myers Squibb (1.38%), Zoetis Inc. (1.13%), Abbott Laboratories (0.84%), Novartis AG (0.22%), Takeda Pharmaceutical Company Limited (0.20%), AstraZeneca PLC (0.28%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Sanofi stock? Short selling SNY is an investing strategy that aims to generate trading profit from Sanofi as its price is falling. SNY shares are trading up $0.70 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sanofi? A short squeeze for Sanofi occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNY, which in turn drives the price of the stock up even further. How often is Sanofi's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNY, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: REGN Short Interest Data VRTX Short Interest Data PFE Short Interest Data GSK Short Interest Data BMY Short Interest Data ZTS Short Interest Data ABT Short Interest Data NVS Short Interest Data TAK Short Interest Data AZN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNY) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDave Ramsey Shocks Millions With US Dollar LunacyAmerican Hartford Gold GroupDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThis 1 Biotech Stock has been shocking the marketsHuge AlertsNext President (Not Trump. Not Biden.)The Freeport SocietyDoes this chart look familiar?InvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold